Bensink M - Search Results

1

Risk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis: a retrospective evaluation using Medicare claims.

Weycker D, Hanau A, Lonshteyn A, Bowers C, Garawin T, Bensink M, Chandler D. Weycker D, et al. Among authors: bensink m. Curr Med Res Opin. 2019 Apr;35(4):725-730. doi: 10.1080/03007995.2018.1519504. Epub 2018 Oct 8. Curr Med Res Opin. 2019. PMID: 30182756

2

Kidney Failure Events, Cardiovascular Disease Events, and All-Cause Mortality in Patients with IgA Nephropathy in a Real-World Database.

Lerma EV, Thakker KM, Bensink ME, Lieblich R, Bunke CM, Gong W, Rava AR, Wang K, Amari DT, Oliveri D, Murphy MV, Cork DMW, Velez JCQ. Lerma EV, et al. Among authors: bensink me. Kidney360. 2024 Mar 1;5(3):427-436. doi: 10.34067/KID.0000000000000379. Epub 2024 Feb 7. Kidney360. 2024. PMID: 38323871 Free PMC article.

3

Cardiovascular, Kidney Failure, and All-Cause Mortality Events in Patients with FSGS in a US Real-World Database.

Velez JCQ, Thakker KM, Bensink ME, Lerma EV, Lieblich R, Bunke CM, Gong W, Wang K, Rava AR, Amari DT, Oliveri D, Murphy MV, Cork DMW. Velez JCQ, et al. Among authors: bensink me. Kidney360. 2024 Aug 1;5(8):1145-1153. doi: 10.34067/KID.0000000000000469. Epub 2024 May 15. Kidney360. 2024. PMID: 38748483 Free PMC article.

4

Travel burden associated with granulocyte colony-stimulating factor administration in a Medicare aged population: a geospatial analysis.

Stephens JM, Bensink M, Bowers C, Hollenbeak CS. Stephens JM, et al. Among authors: bensink m. Curr Med Res Opin. 2018 Aug;34(8):1351-1360. doi: 10.1080/03007995.2017.1358158. Epub 2017 Jul 31. Curr Med Res Opin. 2018. PMID: 28722536

5

Administration options for pegfilgrastim prophylaxis: patient and physician preferences from a cross-sectional survey.

Brett Hauber A, Mange B, Price MA, Wolin D, Bensink M, Kaye JA, Chandler D. Brett Hauber A, et al. Among authors: bensink m. Support Care Cancer. 2018 Jan;26(1):251-260. doi: 10.1007/s00520-017-3841-2. Epub 2017 Aug 7. Support Care Cancer. 2018. PMID: 28785862

6

Risk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis based on real-world data from 2010 to 2015.

Weycker D, Bensink M, Wu H, Doroff R, Chandler D. Weycker D, et al. Among authors: bensink m. Curr Med Res Opin. 2017 Dec;33(12):2115-2120. doi: 10.1080/03007995.2017.1386638. Epub 2017 Oct 16. Curr Med Res Opin. 2017. PMID: 28958156

7

Risk of chemotherapy-induced febrile neutropenia by day of pegfilgrastim prophylaxis in US clinical practice from 2010 to 2015.

Weycker D, Bensink M, Lonshteyn A, Doroff R, Chandler D. Weycker D, et al. Among authors: bensink m. Curr Med Res Opin. 2017 Dec;33(12):2107-2113. doi: 10.1080/03007995.2017.1386858. Epub 2017 Oct 16. Curr Med Res Opin. 2017. PMID: 28958157

8

Response to: McBride A, Campbell K, Bikkina M, et al. Cost-efficiency analyses for the US of biosimilar filgrastim-sndz, reference filgrastim, pegfilgrastim, and pegfilgrastim with on-body injector in the prophylaxis of chemotherapy-induced (febrile) neutropenia. J Med Econ 2017;20:1083-93.

Bensink M, Edwards C, Bowers C, Campbell J. Bensink M, et al. J Med Econ. 2018 Jun;21(6):603-605. doi: 10.1080/13696998.2018.1452747. Epub 2018 Apr 12. J Med Econ. 2018. PMID: 29547012 Free article. No abstract available.

9

Risks and consequences of travel burden on prophylactic granulocyte colony-stimulating factor administration and incidence of febrile neutropenia in an aged Medicare population.

Stephens JM, Bensink M, Bowers C, Hollenbeak CS. Stephens JM, et al. Among authors: bensink m. Curr Med Res Opin. 2019 Feb;35(2):229-240. doi: 10.1080/03007995.2018.1465906. Epub 2018 May 10. Curr Med Res Opin. 2019. PMID: 29661043

10

Risk of chemotherapy-induced febrile neutropenia with same-day versus next-day pegfilgrastim prophylaxis among patients aged ≥65 years: a retrospective evaluation using Medicare claims.

Weycker D, Hanau A, Lonshteyn A, Bowers C, Bensink M, Garawin T, Chandler D. Weycker D, et al. Among authors: bensink m. Curr Med Res Opin. 2018 Sep;34(9):1705-1711. doi: 10.1080/03007995.2018.1495621. Epub 2018 Jul 25. Curr Med Res Opin. 2018. PMID: 29962268

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters